Here are the DEF 14A proxy statements from ProMIS Neurosciences Inc. (PMN) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow PMN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PMN filings page.
ProMIS Neurosciences Inc. is holding its 2026 annual shareholder meeting as a virtual-only webcast on May 20, 2026 at 10:30 a.m. Eastern Time, with a record date of March 23, 2026. Shareholders will elect seven directors, ratify Baker Tilly US, LLP as independent auditor, and vote on an amendment to the 2025 Stock Option and Incentive Plan.
The board is not nominating director Patrick Kirwin for re-election and is putting forward Dr. Slanix Alex as an independent nominee. As of March 23, 2026, 8,967,693 common shares were outstanding, with significant holders including entities affiliated with Janus Henderson at 14.99%. The proxy also details board independence, committee structures, director compensation and a non-employee director pay and option policy.